Form 4 for VNRX VOLITIONRX LTD
Accepted 2022-10-06 00:00:00 ET · period of report 2022-10-04 · accession 0001477932-22-007484 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-06 | 2022-10-04 | VNRX | Michel Gaetan | COO | F - Tax | $1.46 | -6,883 | 34.0K | -17% | -$10.0K | |
| 2022-10-06 | 2022-10-04 | VNRX | Michel Gaetan | COO | A - Grant | $0.00 | +100.0K | 134.0K | +294% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-04 | F | D | 6,883 | $1.46 | 33,997 | D | — | — | (F1) Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 19,905 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction. |
| 2 | Common | Common Stock | 2022-10-04 | A | A | 100,000 | $0.00 | 133,997 | D | — | — | (F2) On October 4, 2022, the reporting person was awarded 100,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of a closing stock price target above $5.00 per share of the Issuer's common stock for a minimum of ten consecutive trading days prior to October 4, 2025, and also subject to time-based vesting in a single installment six months after the timely achievement of the target, if at all. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested |